Stem Cell Spray for Chronic Sinus Infection Treatment
Treatments studied
Part of Infections clinical trials.
This early-stage trial tests a new nasal spray combining stem cell-derived material, an antibiotic, and an enzyme to treat chronic sinus infections caused by a specific bacteria. The goal is to reduce inflammation and infection in people who have had symptoms for over 3 months.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18–65 years
- Chronic sinus infection lasting more than 12 weeks, confirmed by nasal scope showing pus and positive culture for Staphylococcus aureus bacteria
- Symptom severity score (SNOT-22) of 30 or higher
- No sinus surgery in the past 6 months
- No recent antibiotic or steroid nasal spray use (past 2–4 weeks)
- No severe kidney disease, uncontrolled diabetes or high blood pressure, or cancer history
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if transplanting healthy nasal bacteria from a donor can help people with chronic sinusitis. It aims to restore a healthy microbiome in the nose to reduce symptoms like congestion and discharge.
This trial tests a new antibody medicine (CM326) for people with chronic sinusitis and nasal polyps whose symptoms persist despite standard treatments like nasal sprays. It aims to see if the drug can reduce inflammation and improve symptoms.
This study tests a new medicine called CM326 for people with chronic sinusitis and nasal polyps (growths in the nose). It may help if you still have symptoms despite using steroid sprays or if you cannot take steroids.
This trial tests a new injection (SHR-1905) for people with chronic sinusitis and nasal polyps who still have symptoms despite using standard nasal spray treatments. It aims to see if the drug can reduce polyp size and improve symptoms.
This early-stage trial tests a new nasal spray containing exosomes (tiny cell particles), azelastine (an allergy and inflammation fighter), and interferon (an immune booster) for chronic sinusitis—a long-lasting sinus infection. The spray is designed to reduce sinus inflammation and symptoms during flare-ups without needing systemic antibiotics or steroids.
This study tests if using a nebulizer to deliver steroid spray can help people with chronic sinusitis (CRS) without prior sinus surgery. It focuses on improving symptoms like nasal congestion and facial pressure.
Hear when a new Chronic Rhinosinusitis With Nasal Polyps trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.